IFTBFInfant Bacterial Therapeutics AB - Ordinary Shares - Class B
IFTBF
Infant Bacterial Therapeutics AB - Ordinary Shares - Class B0
Mkt Cap
$827.15MVolume
10,000.0052W High
$8.2052W Low
$8.20PE Ratio
-11.25IFTBF Fundamentals
Price
$8.20Prev Close
$8.20Open
$8.2050D MA
$8.20Beta
0.00Avg. Volume
434.78EPS (Annual)
-$0.9612P/B
7.84Rev/Employee
$0.00Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. Its products include IBP-9414 and IBP-1016. The IBP-9414, is a drug candidate contains Lactobacillus reuteri which is a human bacterial strain naturally present in breast milk that improves feeding tolerance in premature infants and IBP-1016, helps in treating gastroschisis, a severe birth defect in infants. The company was founded in 2013 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8
Frequently Asked Questions
What is Market Cap of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the 52-week high for Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the 52-week low for Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is Infant Bacterial Therapeutics AB - Ordinary Shares - Class B stock price today?
What was Infant Bacterial Therapeutics AB - Ordinary Shares - Class B stock price yesterday?
What is the PE ratio of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the Price-to-Book ratio of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the 50-day moving average of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
How many employess does Infant Bacterial Therapeutics AB - Ordinary Shares - Class B has?